Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arformoterol effects on exercise endurance in COPD
NCT00754546Phase 4Completed
- Sponsor
- Dartmouth Health
- Start
- Aug 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of arformoterol in chronic obstructive pulmonary disease (COPD), sponsored by Dartmouth Health. Started Aug 2008; status: completed.
02
Drugs
arformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00754546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00754546.